179 related articles for article (PubMed ID: 34202399)
21. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF
Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083
[TBL] [Abstract][Full Text] [Related]
22. High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers.
Lin SC; Chang IW; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Tian YF
J Cancer; 2017; 8(14):2756-2764. PubMed ID: 28928864
[No Abstract] [Full Text] [Related]
23. Utility of RGNEF in the Prediction of Clinical Prognosis in Patients with Rectal Cancer Receiving Preoperative Concurrent Chemoradiotherapy.
Chen CI; Chen HP; Liu KW; Chien CC; Wei YC
Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054411
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients.
Chen TJ; Hsu BH; Lee SW; Yang CC; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Chou CL; Lai HY
Pathol Oncol Res; 2022; 28():1610537. PubMed ID: 36277959
[No Abstract] [Full Text] [Related]
25. Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
[TBL] [Abstract][Full Text] [Related]
26. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
[TBL] [Abstract][Full Text] [Related]
27. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.
Chen YT; Tseng TT; Tsai HP; Kuo SH; Huang MY; Wang JY; Chai CY
Hum Cell; 2022 Nov; 35(6):1912-1927. PubMed ID: 36053457
[TBL] [Abstract][Full Text] [Related]
28. Preoperative endoscopic tattooing technique improved lymph node retrieval in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
Chen YT; Wang JY; Wang JW; Chai CY
J Clin Pathol; 2020 May; 73(5):267-272. PubMed ID: 31690565
[TBL] [Abstract][Full Text] [Related]
29. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
[TBL] [Abstract][Full Text] [Related]
30. Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.
Lin CY; Lin CY; Chang IW; Sheu MJ; Li CF; Lee SW; Lin LC; Lee YE; He HL
Am J Transl Res; 2015; 7(11):2423-32. PubMed ID: 26807188
[TBL] [Abstract][Full Text] [Related]
31. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
[TBL] [Abstract][Full Text] [Related]
32. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
33. PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis.
Chou CL; Chen TJ; Lin CY; Lee SW; Wang SC; Chu SS; Yang CC
Onco Targets Ther; 2020; 13():3141-3150. PubMed ID: 32346297
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy.
Su YT; Chen CH; Kang JW; Kuo HY; Yang CC; Tian YF; Yeh CF; Chou CL; Chen SH
Aging (Albany NY); 2024 May; 16(9):7889-7901. PubMed ID: 38709264
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of DSG3 in rectal adenocarcinoma treated with preoperative chemoradiotherapy.
Chao TB; Li CF; Lin CY; Tian YF; Chang IW; Sheu MJ; Lee YE; Chan TC; He HL
Future Oncol; 2016 Jun; 12(12):1457-67. PubMed ID: 27040321
[TBL] [Abstract][Full Text] [Related]
37. High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Lin CY; Lee YE; Tian YF; Sun DP; Sheu MJ; Lin CY; Li CF; Lee SW; Lin LC; Chang IW; Wang CT; He HL
J Cancer; 2017; 8(6):1089-1096. PubMed ID: 28529623
[No Abstract] [Full Text] [Related]
38. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
Hsu YC; Luo CW; Huang WL; Wu CC; Chou CL; Chen CI; Chang SJ; Chai CY; Wang HC; Chen TY; Li CF; Pan MR
Radiother Oncol; 2020 Aug; 149():249-258. PubMed ID: 32592893
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
[TBL] [Abstract][Full Text] [Related]
40. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
